Press Releases Choose Year All Items 2026 2025 2024 Search Press Releases Found 25 Results March 9, 2026 LB Pharmaceuticals Appoints R&D Biotech Executive Robert Lenz, M.D., Ph.D. to Board of Directors March 4, 2026 LB Pharmaceuticals to Participate in Upcoming March Investor Events February 10, 2026 LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) February 5, 2026 LB Pharmaceuticals Announces $100.0 Million Private Placement January 26, 2026 LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program January 21, 2026 LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General Counsel January 12, 2026 LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) January 6, 2026 LB Pharmaceuticals Strengthens Leadership Team with Key Appointments in Corporate Affairs and People & Culture December 10, 2025 LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) December 9, 2025 LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices 123»
